IBM中心特別邀請到Rice University的Prof. Ashutosh Sabharwal前來為我們演講，歡迎有興趣的老師與同學免費報名參加！
演講標題：CPLink: Interference-free Reuse of Cyclic-Prefix Duration
演講者：Prof. Ashutosh Sabharwal (Dept. ECE, Rice University)
時間：2018/07/26 (四) 14:00 ~ 15:00 AM
地點：交大工程四館528室
主辦單位：交大-IBM智慧物聯網巨量資料研發中心
Abstract
Next-generation cellular networks will use massive MIMO, which favors time-division duplexing between the uplink and downlink. We propose a new simple idea to reuse the cyclic prefix durations for additional simultaneous communications in time-division duplex networks. Labeled CPLink, the on-off communication link is active only during the cyclic prefix durations of ongoing downlink OFDM communications. We prove a zero-knowledge CPLink capacity result, which allows distributed operation of CPLink, without any knowledge of where the CPLink transmitters are located in relation to the receivers of ongoing communications. CPLink can be generally used for both data and control in TDD networks; we discuss several applications.
Bio of Speaker
Ashutosh Sabharwal is a Professor of Electrical and Computer Engineering in Rice University, Houston, Texas. He works in two areas. His first area of research is wireless communications. He is the founder of WARP project (warp.rice.edu), an open-source project which is now in use at more than 125 research groups worldwide, and have been used by more than 450 research articles. His research in wireless has spanned both fundamental theory and experimental systems. He is a Fellow of IEEE for his contributions to the theory and experimentation in wireless systems and communications. He received 2017 Jack Neubauer Memorial Award and 2018 Advances in Communications award for his innovations in full-duplex wireless. The second area of research is bio-behavioral sensing for next-generation healthcare systems. He founded the Rice Scalable Health Labs (http://sh.rice.edu), which is establishing the foundations for bio-behavioral sensing, applied to many healthcare problems, e.g. mental health, pulmonology, surgery and chronic disease management. Till day, his research has led to four commercial spinoffs.
